An announcement from China Touyun Tech Group ( (HK:1332) ) is now available.
Touyun Biotech Group Limited has announced its intention to adopt a new share option scheme while terminating the existing one, which was initially adopted in June 2022. The new scheme aims to align with the amended Chapter 17 of the Listing Rules effective from January 2023, and is designed to attract and retain high-caliber personnel by providing additional incentives and promoting the company’s long-term growth and profitability. The adoption of the new scheme is subject to shareholder approval and regulatory permissions.
More about China Touyun Tech Group
YTD Price Performance: -8.42%
Average Trading Volume: 143,577
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$488.2M
See more insights into 1332 stock on TipRanks’ Stock Analysis page.